GenMark Diagnostics (GNMK) Posts Q2 Loss of 39c, Narrower than Views
Tweet
Share
E-mailGet Alerts GNMK Hot Sheet
Join SI Premium – FREE
GenMark Diagnostics (NASDAQ: GNMK) reported Q2 EPS of ($0.39), $0.14 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $901 thousand versus the consensus estimate of $860 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
